Notice: This company has been marked as potentially delisted and may not be actively trading. Soaring Eagle Acquisition (SRNG) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends SRNG vs. HALO, RVMD, KRYS, SRRK, ALVO, ADMA, ACLX, CRSP, IMVT, and DNLIShould you be buying Soaring Eagle Acquisition stock or one of its competitors? The main competitors of Soaring Eagle Acquisition include Halozyme Therapeutics (HALO), Revolution Medicines (RVMD), Krystal Biotech (KRYS), Scholar Rock (SRRK), Alvotech (ALVO), ADMA Biologics (ADMA), Arcellx (ACLX), CRISPR Therapeutics (CRSP), Immunovant (IMVT), and Denali Therapeutics (DNLI). Soaring Eagle Acquisition vs. Halozyme Therapeutics Revolution Medicines Krystal Biotech Scholar Rock Alvotech ADMA Biologics Arcellx CRISPR Therapeutics Immunovant Denali Therapeutics Halozyme Therapeutics (NASDAQ:HALO) and Soaring Eagle Acquisition (NASDAQ:SRNG) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, community ranking, institutional ownership, earnings, media sentiment and analyst recommendations. Do institutionals and insiders hold more shares of HALO or SRNG? 97.8% of Halozyme Therapeutics shares are owned by institutional investors. Comparatively, 41.2% of Soaring Eagle Acquisition shares are owned by institutional investors. 2.4% of Halozyme Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media prefer HALO or SRNG? In the previous week, Halozyme Therapeutics had 7 more articles in the media than Soaring Eagle Acquisition. MarketBeat recorded 7 mentions for Halozyme Therapeutics and 0 mentions for Soaring Eagle Acquisition. Halozyme Therapeutics' average media sentiment score of 1.24 beat Soaring Eagle Acquisition's score of 0.20 indicating that Halozyme Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Halozyme Therapeutics Positive Soaring Eagle Acquisition Neutral Do analysts rate HALO or SRNG? Halozyme Therapeutics currently has a consensus target price of $60.89, suggesting a potential upside of 7.92%. Given Halozyme Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Halozyme Therapeutics is more favorable than Soaring Eagle Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Halozyme Therapeutics 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.60Soaring Eagle Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community prefer HALO or SRNG? Halozyme Therapeutics received 524 more outperform votes than Soaring Eagle Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformHalozyme TherapeuticsOutperform Votes52469.40% Underperform Votes23130.60% Soaring Eagle AcquisitionN/AN/A Which has better earnings and valuation, HALO or SRNG? Halozyme Therapeutics has higher revenue and earnings than Soaring Eagle Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHalozyme Therapeutics$829.25M8.66$281.59M$3.0218.68Soaring Eagle AcquisitionN/AN/AN/AN/AN/A Is HALO or SRNG more profitable? Halozyme Therapeutics has a net margin of 41.43% compared to Soaring Eagle Acquisition's net margin of 0.00%. Halozyme Therapeutics' return on equity of 179.82% beat Soaring Eagle Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets Halozyme Therapeutics41.43% 179.82% 23.56% Soaring Eagle Acquisition N/A N/A N/A SummaryHalozyme Therapeutics beats Soaring Eagle Acquisition on 12 of the 12 factors compared between the two stocks. Get Soaring Eagle Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRNG vs. The Competition Export to ExcelMetricSoaring Eagle AcquisitionBiological Products, Except Diagnostic IndustryEnergy SectorNASDAQ ExchangeMarket Cap$2.64B$3.09B$9.19B$9.14BDividend YieldN/A1.87%11.58%3.98%P/E RatioN/A46.7413.3417.66Price / SalesN/A297.5745.6581.09Price / CashN/A188.8912.0837.71Price / BookN/A4.144.374.73Net IncomeN/A-$40.99M$947.35M$225.42M Soaring Eagle Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRNGSoaring Eagle AcquisitionN/A$12.25-0.2%N/A+851.9%$2.64BN/A0.00N/AHALOHalozyme Therapeutics4.5439 of 5 stars$55.94+2.1%$60.89+8.8%+62.2%$7.12B$829.25M18.52390Short Interest ↑Positive NewsRVMDRevolution Medicines4.3754 of 5 stars$40.16-0.3%$66.25+65.0%+41.7%$6.76B$11.58M-11.19250KRYSKrystal Biotech4.8534 of 5 stars$151.55+2.1%$206.67+36.4%+31.2%$4.36B$241.52M85.62210Short Interest ↓SRRKScholar Rock3.304 of 5 stars$44.88+4.1%$40.43-9.9%+180.7%$4.20B$33.19M-19.10140Analyst ForecastNews CoverageALVOAlvotech2.9972 of 5 stars$13.36+0.7%$18.00+34.7%-17.6%$4.03B$93.38M-7.221,026Short Interest ↓ADMAADMA Biologics4.1804 of 5 stars$16.16+0.9%$21.25+31.5%+207.3%$3.82B$258.21M57.71530Short Interest ↑ACLXArcellx2.9838 of 5 stars$66.57+0.1%$105.93+59.1%+0.3%$3.60B$110.32M-93.7680Short Interest ↑CRSPCRISPR Therapeutics2.6756 of 5 stars$41.51+2.4%$78.38+88.8%-37.4%$3.54B$200M-14.67473Short Interest ↑News CoverageGap UpIMVTImmunovant1.751 of 5 stars$23.59-1.1%$47.00+99.2%-44.6%$3.46BN/A-10.63120DNLIDenali Therapeutics4.499 of 5 stars$23.04+5.1%$38.91+68.9%+33.6%$3.32B$330.53M-8.35430Analyst ForecastShort Interest ↑ Related Companies and Tools Related Companies HALO Alternatives RVMD Alternatives KRYS Alternatives SRRK Alternatives ALVO Alternatives ADMA Alternatives ACLX Alternatives CRSP Alternatives IMVT Alternatives DNLI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SRNG) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soaring Eagle Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soaring Eagle Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRNG Stock Alerts